Insight that Drives the Boardroom

Stay ahead with data-backed research, governance analysis, and expert commentary for investors, activists, and corporate leaders.

Activism & Governance

Executive Moves Update – October 17, 2025

This week’s transitions include CEO changes at Verizon, LendingTree, and Kemper, plus CFO shifts at Becton Dickinson, Ameren, Ardelyx, and Starboard placing Peter Feld at Bill.

Executive Moves Update – October 10, 2025

Core Natural Resources, Acadia Healthcare, and Campbell’s replace top leaders amid performance struggles, while Diebold Nixdorf, IDEXX, and Dycom strengthen leadership following strong results.

Executive Moves Update – September 19, 2025

Struggling Crown Castle names Christian Hillabrant CEO, Dexcom appoints interim leaders, Canopy Growth installs CFO amid losses, Bank of America strengthens leadership team. See this week’s key executive moves.

SPAC & IPO Analysis

Daily SPAC Update – March 10, 2026

Plum IV + Controlled Thermal Resources and Calisa + GoodVision AI Deals. TLGY + Stabecoin X Assets Deal Vote. DMY Squared PIPE Updates.

Daily SPAC Update – March 9, 2026

Drugs Made in America CEO Lynn Stockwell Terminated after Improper Withdrawals. DMY Squared Increases PIPE. Plum IV $4.7B Deal with CTR.

Daily SPAC Update – March 5, 2026

Gundlach’s Bleichroeder II Does Quantum Deal with Pasqal. AParadise Target Enhanced Issues Investor Deck. Goldenstone Sets Extension Vote.

Daily SPAC Update – March 3, 2026

Alex Rodriguez’s SLAM Corp gets a new Sponsor and pivots to crypto. Newbridge and Keen Vision move towards deals. Crane Harbor and Uy Scuti votes set.

Daily SPAC Update – March 2, 2026

SPAC market looks strong with $5.5B+ raised across 27 IPO in February. But, can the existing deals get done and existing capital find deals?

Get it In Your Inbox

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.